Investors Capital Advisory Services’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,256	Closed	-$204K	–	748
2015 Q2	$204K	Buy	+3,256	New	+$204K	0.04%	610